Joseph Stringfellow

Aripiprazole, an Antipsychotic With a Novel Mechanism of Action, and Risperidone vs Placebo in Patients With Schizophrenia and Schizoaffective Disorder

Steven G. Potkin, Anutosh Ranjan Saha, Mary J. Kujawa et al. · Archives of General Psychiatry · 2003 · 590 citations

Gepirone Treatment of Atypical Depression

Patrick J. McGrath, Jonathan W. Stewart, Frederic M. Quitkin et al. · Journal of Clinical Psychopharmacology · 1994 · 52 citations

Psychopathology, Psychotropic Medication, Psychopharmacology +16

P‐Glycoprotein and Breast Cancer Resistance Protein Transporter Inhibition by Cyclosporine and Quinidine on the Pharmacokinetics of Oral Rimegepant in Healthy Subjects

Rajinder Bhardwaj, Julie L. Collins, Joseph Stringfellow et al. · Clinical Pharmacology in Drug Development · 2022 · 24 citations · Full text

A phase 1 randomized study of hemodynamic effects and pharmacokinetic interactions during concomitant use of rimegepant and sumatriptan in healthy adults

Robert Croop, Andrea Ivans, Matt S. Anderson et al. · Cephalalgia Reports · 2021 · 16 citations · Full text

Pharmacokinetic Interactions, Pharmacotherapy, Logistic Analysis +18

Efficacy of aripiprazole, a novel antipsychotic, in schizophrenia and schizoaffective disorder: Results of a placebo-controlled trial with risperidone

Paul Yeung, William H. Carson, Apurba Kumar Saha et al. · European Neuropsychopharmacology · 2001 · 13 citations

Psychiatry, Psychotic Disorder, Pharmacology +8